As of Aug 26
| -0.1727 / -8.25%|
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,983.33% increase from the last price of 1.92.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.